Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
69.48 CAD | -1.61% | -4.11% | +19.52% |
04-15 | Morgan Stanley Raises Price Target on Ovintiv to $53 From $49, Keeps Equalweight Rating | MT |
04-12 | Ovintiv Maintained at Buy at TPH Ahead of Q1 Results; Price Target at US$66.00 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.97% | 297B | |
+7.28% | 147B | |
+56.15% | 128B | |
+19.13% | 81.38B | |
+7.76% | 76B | |
+18.43% | 62.92B | |
+8.45% | 58.63B | |
+8.38% | 48.36B | |
+26.89% | 35.87B |
- Stock Market
- Equities
- OVV Stock
- OVV Stock
- News Ovintiv Inc.
- Ovintiv : Morgan Stanley Adjusts Price Target on Ovintiv to $42 From $35, Maintains Overweight Rating